ConductScience.org, home

Library / Trials

Cognitive Therapy for Urinary Dysfunction in Parkinson´s Disease

NCT03917732, Not applicable, Unknown, University Hospital Schleswig-Holstein

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleCognitive Therapy for Urinary Dysfunction in Parkinson´s DiseaseClinicalTrials.gov
NCT numberNCT03917732ClinicalTrials.gov
StatusUnknownClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment45 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity Hospital Schleswig-HolsteinClinicalTrials.gov
ConditionsParkinson Disease, Urinary Disease OtherClinicalTrials.gov
Interventionscognitive training, pelvic floor trainingClinicalTrials.gov
First posted2019-04-17ClinicalTrials.gov
Last updated2019-04-17ClinicalTrials.gov

Registered outcomes 12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in the International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)4 weeks before beginning and 4 weeks after completion of the training
The ICIQ-OAB is a questionnaire for evaluating overactive bladder and related impact on quality of life (QoL) and outcome of treatment in men and women in research and clinical practice across the world. The ICIQ-OAB is derived from the fully validated ICSmale and BFLUTS questionnaires and provides a measure to assess the impact of urinary frequency, urgency, urge incontinence and nocturia symptoms.
ClinicalTrials.gov
PrimaryChange in the International Consultation on Incontinence Questionnaire Lower Urinary Tract Symptoms Quality of Life Module (ICIQ-LUTSqol)4 weeks before beginning and 4 weeks after completion of the training
The ICIQ-LUTSqol is a psychometrically robust patient-completed questionnaire evaluating quality of life (QoL) in urinary incontinent patients for use in research and clinical practice across the world. The ICIQ-LUTSqol is the King's Health Questionnaire (KHQ) adapted for use within the ICIQ structure and provides a measure to assess the impact of urinary incontinence on quality of life with particular reference to social effects. It is an ideal research tool as it explores in detail the impact on patients' lives of urinary incontinence and can be used as an outcome measure to assess impact of different treatment modalities.
ClinicalTrials.gov
PrimaryChange in the Patient Perception of Bladder Condition (PPBC)4 weeks before beginning and 4 weeks after completion of the trainingThe PPBC is a single-item, global outcome measure for urinary incontinence.ClinicalTrials.gov
PrimaryChange in the International Prostate Symptom Score (I-PSS)4 weeks before beginning and 4 weeks after completion of the training
The International Prostate Symptom Score (I-PSS) is based on the answers to seven questions concerning urinary symptoms and one question concerning quality of life. Each question concerning urinary symptoms allows the patient to choose one out of six answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).
ClinicalTrials.gov
PrimaryChange in the Uroflowmetric4 weeks before beginning and 4 weeks after completion of the trainingUroflowmetry measures the flow of urine. It tracks how fast urine flows, how much flows out, and how long it takes. It's a diagnostic test to assess how well the urinary tract functions.ClinicalTrials.gov
SecondaryChange in the Verbal memory function through the Rey Auditory Verbal Learning Test (RAVLT)4 weeks before beginning and 4 weeks after completion of the training
Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. Another list of 15 unrelated words are given and the client must again repeat the original list of 15 words and then again after 30 minutes.
ClinicalTrials.gov
SecondaryChange in the Visuomotor abilities and nonverbal memory Rey-Osterrieth complex figure test (ROCF)4 weeks before beginning and 4 weeks after completion of the training
The Rey-Osterrieth complex figure test (ROCF) is a neuropsychological assessment in which patients are asked to reproduce a complicated line drawing, first by copying it freehand (recognition; measures visuomotor abilities), and then drawing from memory (recall; measures nonverbal memory).
ClinicalTrials.gov
SecondaryChange in the Verbal short term memory functions through the Digit Span test4 weeks before beginning and 4 weeks after completion of the training
Verbal short term memory span measures the number of discrete units over which the patient can successively distribute his attention and still organize them into a working unit. To generalize, it refers to the ability of the patient to reproduce immediately, after one presentation, a series of discrete stimuli in their original order.
ClinicalTrials.gov
SecondaryChange in the Response inhibition through the Stroop test4 weeks before beginning and 4 weeks after completion of the trainingThe Stroop test is a widely used measure of selective attention that requires interference resolution, response inhibition, and response selection.ClinicalTrials.gov
SecondaryChange in the Visual attention and task switching though the Trial Making Test4 weeks before beginning and 4 weeks after completion of the training
The Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy.
ClinicalTrials.gov
SecondaryChange in the Word fluency through the Regensburger Word Fluency Test4 weeks before beginning and 4 weeks after completion of the trainingIn the Regensburger Word Fluency Test patients have to produce as many words as possible from a given category or beginning with a specific letter within 2 minutes.ClinicalTrials.gov
OtherChanges in functional magnet resonance imaging (fMRI) within a Go/NoGo paradigm4 weeks before beginning and 4 weeks after completion of the training
The investigators aim to answer the question whether there are different activity patterns in Parkinson's patients with bladder dysfunction compared to Parkinson's patients without bladder dysfunction in the areas involved in bladder function regulation while concerning a Go/NoGo paradigm.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 8

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Complex Figure Copy and RecallSecondary outcomeConductCognition
Digit Span TestSecondary outcomeConductCognition
Go/No-Go TaskOther outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Task Switching TestSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition
Verbal LearningSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)